Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity.
Watanabe R, Shirai T, Namkoong H, Zhang H, Berry GJ, Wallis BB, Schaefgen B, Harrison DG, Tremmel JA, Giacomini JC, Goronzy JJ, Weyand CM.
Watanabe R, et al.
J Clin Invest. 2017 Jun 30;127(7):2725-2738. doi: 10.1172/JCI92167. Epub 2017 Jun 12.
J Clin Invest. 2017.
PMID: 28604383
Free PMC article.